<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00639379</url>
  </required_header>
  <id_info>
    <org_study_id>CR-0802</org_study_id>
    <nct_id>NCT00639379</nct_id>
  </id_info>
  <brief_title>Comparison of Two Toric Contact Lenses on Current Toric Wearers</brief_title>
  <official_title>A Multi-Center, Subject Masked, Randomized, Two Week Crossover Design, Investigation of the Acuvue Cypress Toric Silicone Hydrogel Lens Compared to the Bausch &amp; Lomb SofLens66® Toric Hydrophilic Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate and compare the clinical performance of two toric
      contact lenses amongst 110 subjects, 2-week, single masked (subject), daily wear, randomized,
      bilateral, crossover study; 4 weeks duration. Hypotheses include equal or better performance
      of the test lens over the control lenses for comfort, vision, and toric fit characteristics
      as well as corneal integrity
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 7 sites in the US will participate. Each investigator will have both test and control
      lens types. There will be a maximum of 6 scheduled visits:

      Visit 1: Habitual lens evaluation / Baseline / Trial fitting Visit 2: Dispensing (to be
      combined with Visit 1 where possible), Visit 3: Questionnaire only (no exam) 7 days (±2)
      after dispensing, Visit 4: 2 week follow-up 14 days (±3) after dispensing, and dispense
      second lens type, Visit 5: Questionnaire only (no exam) 7 days (±2) after 2nd lens dispense,
      Visit 6: 2 week follow-up 14 days (±3) after 2nd lens dispense
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">June 2008</completion_date>
  <primary_completion_date type="Actual">June 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lens Orientation Within 5 Degrees</measure>
    <time_frame>1 minute after insertion</time_frame>
    <description>Number of eyes with lens orientation within 5 degrees of optimal orientation within 1 minute of contact lens insertion.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lens Stability</measure>
    <time_frame>10-15 minutes after insertion</time_frame>
    <description>Number of eyes with the amount of rotation induced from a blink within 5 degrees of settled orientation.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Lens Comfort</measure>
    <time_frame>1 and 2 weeks</time_frame>
    <description>A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control. &gt;0=comfortable, &lt;0=uncomfortable.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subjective Vision</measure>
    <time_frame>1 and 2 weeks</time_frame>
    <description>A weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive vision outcomes. The analysis shows the difference in outcome between the test and control. &gt;0=satisfactory vision, &lt;0=unsatisfactory vision.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Overall Corneal Staining</measure>
    <time_frame>after 2 weeks use</time_frame>
    <description>Corneal staining measured using the National Eye Institute grading scale of grade 0 = normal, grade 1 = mild, grade 2 = moderate, grade 3 = severe.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">89</enrollment>
  <condition>Ametropia</condition>
  <arm_group>
    <arm_group_label>senofilcon A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>senofilcon A toric daily wear contact lenses</description>
  </arm_group>
  <arm_group>
    <arm_group_label>alphafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>alphafilcon A toric daily wear contact lenses</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon A toric</intervention_name>
    <description>silicone hydrogel toric lens, 2 wk replacement, daily wear</description>
    <arm_group_label>senofilcon A</arm_group_label>
    <other_name>ACUVUE OASYS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>alphafilcon A toric</intervention_name>
    <description>hydrogel toric lens, 2 wk replacement, daily wear</description>
    <arm_group_label>alphafilcon A</arm_group_label>
    <other_name>SofLens Toric</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Be at least 18 and less than or equal to 45 years of age, have a need for vision
             correction and wear contact lenses in BOTH eyes (monovision or uni-ocular fitting is
             NOT allowed).

          2. Be able to read J1 at near WITHOUT the aid of a near addition over the distance
             prescription.

          3. Be a currently successful wearer for at least 3 months of B&amp;L SofLens 66 Toric
             hydrogel lenses.

          4. Be able and willing to adhere to the instructions set forth in the protocol.

          5. Agree to wear their contact lenses in both eyes on a daily wear schedule for at least
             8 hours per day every day during the study.

          6. Have a distance spectacle spherical component between -1.00 D and -5.25 D with
             cylinder in the range of 0.75 D to 2.25 D and cylinder axis within 10 ° of the
             vertical and within 30° of the horizontal in both eyes (when the subject's
             prescription is presented in minus cylinder form).

          7. Have a best corrected manifest refraction visual acuity of at least 20/25 or better in
             each eye.

          8. Be in good general health, based on his/her knowledge.

          9. Must be given an explanation of the study objectives, lens and solutions usage
             requirements and visit schedule. The subject must read, indicate understanding of and
             agree to begin participation in the clinical study. The subject must then sign the
             Informed Consent Form in the presence of the Investigator or their designee.

        Exclusion Criteria:

          1. Presbyopic or has the need for a near add for reading.

          2. Previous refractive surgery; current or previous orthokeratology treatment.

          3. Aphakia, keratoconus or a highly irregular cornea.

          4. The presence of ocular or systemic disease or has the need for medication (ocular or
             systemic) which might interfere with contact lens wear or which would cause the lenses
             to be removed more than twice a day. (e.g., Sjögren's syndrome, type II diabetes,
             allergies).

          5. A known history of corneal hypoesthesia (reduced corneal sensitivity.)

          6. Anterior uveitis or iritis (past or present).

          7. A history of recurrent erosions, corneal infiltrates corneal ulcer or fungal
             infections.

          8. Clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations or
             infections of the eye, eyelids, or associated structures.

          9. Slit lamp findings that would contraindicate contact lens wear such as:

               -  Pathological dry eye or associated findings

               -  Pterygium or corneal scars within the visual axis

               -  Neovascularization &gt;1mm in from the limbus

               -  History of giant papillary conjunctivitis (GPC) worse than Grade 2

               -  Meibomian gland dysfunction, blepharitis, or seborrhoeic dermatitis

         10. Current pregnancy or lactation (to the best of the subject's knowledge).

         11. Actively participating in another clinical study at any time during this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ted Brink and Associates</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eola Eyes</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clayton Eye Center</name>
      <address>
        <city>Morrow</city>
        <state>Georgia</state>
        <zip>30260</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Koetting Associates Inc.</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63144</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern Eyes</name>
      <address>
        <city>Concord</city>
        <state>North Carolina</state>
        <zip>28025</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western Reserve Vision Care</name>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primary Eyecare Group, P.C.</name>
      <address>
        <city>Brentwood</city>
        <state>Tennessee</state>
        <zip>37027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2008</study_first_submitted>
  <study_first_submitted_qc>March 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2008</study_first_posted>
  <results_first_submitted>June 18, 2010</results_first_submitted>
  <results_first_submitted_qc>June 18, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 19, 2010</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>toric contact lenses</keyword>
  <keyword>vision</keyword>
  <keyword>comfort</keyword>
  <keyword>toric fit characteristics</keyword>
  <keyword>slit lamp findings</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Senofilcon A Toric / Alphafilcon A Toric</title>
          <description>senofilcon A toric work bilaterally during first 2-week period, alphafilcon A toric work bilaterally during second 2-week period.</description>
        </group>
        <group group_id="P2">
          <title>Alphafilcon A Toric / Senofilcon A Toric</title>
          <description>alphafilcon A toric work bilaterally during first 2-week period, senofilcon A toric work bilaterally during second 2-week period.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1 - 2 Weeks</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>lens issue</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 2 - 2 Weeks</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Total Completed Participants</title>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="84"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31.6" spread="8.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Lens Orientation Within 5 Degrees</title>
        <description>Number of eyes with lens orientation within 5 degrees of optimal orientation within 1 minute of contact lens insertion.</description>
        <time_frame>1 minute after insertion</time_frame>
        <population>Subjects/eyes that completed the study were analyzed. A total of 168 eyes/84 subjects were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
          </group>
          <group group_id="O2">
            <title>Alphafilcon A Toric</title>
          </group>
        </group_list>
        <measure>
          <title>Lens Orientation Within 5 Degrees</title>
          <description>Number of eyes with lens orientation within 5 degrees of optimal orientation within 1 minute of contact lens insertion.</description>
          <population>Subjects/eyes that completed the study were analyzed. A total of 168 eyes/84 subjects were analyzed.</population>
          <units>Eyes</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="84"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128"/>
                    <measurement group_id="O2" value="128"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is that senofilcon A toric is non-inferior to alphafilcon A toric for proportion of eyes with lens orientation within 5 degrees.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin is 0.65</non_inferiority_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>0.967</param_value>
            <ci_percent>98.98</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.436</ci_lower_limit>
            <ci_upper_limit>0.967</ci_upper_limit>
            <estimate_desc>Odds ratio is senofilcon A toric / alphafilcon A toric.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Lens Stability</title>
        <description>Number of eyes with the amount of rotation induced from a blink within 5 degrees of settled orientation.</description>
        <time_frame>10-15 minutes after insertion</time_frame>
        <population>Subjects/eyes that completed the study were analyzed. A total of 168 eyes/84 subjects were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
          </group>
          <group group_id="O2">
            <title>Alphafilcon A Toric</title>
          </group>
        </group_list>
        <measure>
          <title>Lens Stability</title>
          <description>Number of eyes with the amount of rotation induced from a blink within 5 degrees of settled orientation.</description>
          <population>Subjects/eyes that completed the study were analyzed. A total of 168 eyes/84 subjects were analyzed.</population>
          <units>Eyes</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="84"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="144"/>
                    <measurement group_id="O2" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is that senofilcon A toric is non-inferior to alphafilcon A toric for proportion of eyes with lens stability within 5 degrees.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = 0.65</non_inferiority_desc>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>1.416</param_value>
            <ci_percent>98.98</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.680</ci_lower_limit>
            <ci_upper_limit>1.416</ci_upper_limit>
            <estimate_desc>Odds ratio is senofilcon A toric / alphafilcon A toric.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Lens Comfort</title>
        <description>A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control. &gt;0=comfortable, &lt;0=uncomfortable.</description>
        <time_frame>1 and 2 weeks</time_frame>
        <population>Subjects that completed the study were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
          </group>
          <group group_id="O2">
            <title>Alphafilcon A Toric</title>
          </group>
        </group_list>
        <measure>
          <title>Subjective Lens Comfort</title>
          <description>A weighted combined score calculated from individual comfort-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive comfort outcomes. The analysis shows the difference in outcome between the test and control. &gt;0=comfortable, &lt;0=uncomfortable.</description>
          <population>Subjects that completed the study were analyzed.</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="84"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08125" spread="0.08771"/>
                    <measurement group_id="O2" value="-0.1055" spread="0.08771"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is that senofilcon A toric is non-inferior to alphafilcon A toric for lens comfort.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = -0.4</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.1868</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.0921</dispersion_value>
            <ci_percent>98.98</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.0517</ci_lower_limit>
            <ci_upper_limit>0.1868</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as senofilcon A toric minus alphafilcon A toric.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subjective Vision</title>
        <description>A weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive vision outcomes. The analysis shows the difference in outcome between the test and control. &gt;0=satisfactory vision, &lt;0=unsatisfactory vision.</description>
        <time_frame>1 and 2 weeks</time_frame>
        <population>Subjects that completed the study were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
          </group>
          <group group_id="O2">
            <title>Alphafilcon A Toric</title>
          </group>
        </group_list>
        <measure>
          <title>Subjective Vision</title>
          <description>A weighted combined score calculated from individual vision-related questions asked on a 1-5 scale: 1=most negative response to 5=most positive response, was used to derive vision outcomes. The analysis shows the difference in outcome between the test and control. &gt;0=satisfactory vision, &lt;0=unsatisfactory vision.</description>
          <population>Subjects that completed the study were analyzed.</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="84"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.0420" spread="0.08885"/>
                    <measurement group_id="O2" value="-0.0302" spread="0.08885"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is that senofilcon A toric is non-inferior to alphafilcon A toric for subjective vision.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = -0.4</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.01185</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.08566</dispersion_value>
            <ci_percent>98.98</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.2337</ci_lower_limit>
            <ci_upper_limit>-0.01185</ci_upper_limit>
            <estimate_desc>The mean difference is calculated as senofilcon A toric minus alphafilcon A toric.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Overall Corneal Staining</title>
        <description>Corneal staining measured using the National Eye Institute grading scale of grade 0 = normal, grade 1 = mild, grade 2 = moderate, grade 3 = severe.</description>
        <time_frame>after 2 weeks use</time_frame>
        <population>Subjects that completed the study were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A Toric</title>
          </group>
          <group group_id="O2">
            <title>Alphafilcon A Toric</title>
          </group>
        </group_list>
        <measure>
          <title>Overall Corneal Staining</title>
          <description>Corneal staining measured using the National Eye Institute grading scale of grade 0 = normal, grade 1 = mild, grade 2 = moderate, grade 3 = severe.</description>
          <population>Subjects that completed the study were analyzed.</population>
          <units>Units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="84"/>
                <count group_id="O2" value="84"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.04921" spread="0.01174"/>
                    <measurement group_id="O2" value="0.06188" spread="0.01176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis is senofilcon A toric is non-inferior to alphafilcon A toric by having a lower level of corneal staining.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>Non-inferiority margin = 0.5</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.01267</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.01265</dispersion_value>
            <ci_percent>98.98</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.01267</ci_lower_limit>
            <ci_upper_limit>0.01986</ci_upper_limit>
            <estimate_desc>The mean difference was calculated as senofilcon A toric minus alphafilcon A toric.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Senofilcon A Toric / Alphafilcon A Toric</title>
          <description>senofilcon A toric work bilaterally during first 2-week period, alphafilcon A toric work bilaterally during second 2-week period.</description>
        </group>
        <group group_id="E2">
          <title>Alphafilcon A Toric / Senofilcon A Toric</title>
          <description>alphafilcon A toric work bilaterally during first 2-week period, senofilcon A toric work bilaterally during second 2-week period.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="45"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Kurt Moody, OD</name_or_title>
      <organization>Vistakon</organization>
      <phone>904-443-3088</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

